Two people can have very different responses to the same drug and treatment. It is becoming clearer that the different responses relate to a person's genetic makeup.
The treatment of breast cancer is one of the first to take into account a person's genetics.
Chronic Myloid Lukemia and Lung Cancer are two types of cancer that have been successfully treated by targeting the proteins that lead to the overactivation of otherwise normal cellular processes. Using specifically designed drugs to target these activators can treat some forms of cancer with dramatically successful results.